ARTICLE | Company News
GPC Biotech in alliance with Aventis
December 15, 2000 8:00 AM UTC
GPC will use its PathCode technology protein interaction mapping technology to identify and validate proteins that interact with one of AVE's drug discovery targets. Separately, the companies are coll...